Clinical trial
Use of Biomarker Risk Score to Optimize Therapy in Patients With Coronary Artery Disease: The Precision CAD Trial
NCT04755413 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Biomarker Risk Score to Optimize Therapy in Patients With Coronary Artery Disease: The Precision CAD Trial
- Lead sponsor
- Emory University
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 19, 2022
- Completion date
- December 31, 2028
- Enrollment
- 276 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.